KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
62 hedge funds and large institutions have $91M invested in Kinnate Biopharma Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
100% less call options, than puts
Call options by funds: $20K | Put options by funds: $4.83M
Holders
62
Holding in Top 10
4
Calls
$20K
Puts
$4.83M
Top Buyers
| 1 | +$6.17M | |
| 2 | +$1.33M | |
| 3 | +$1.11M | |
| 4 |
AI
Acuitas Investments
Seattle,
Washington
|
+$687K |
| 5 |
Two Sigma Investments
New York
|
+$384K |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$1.53M | |
| 3 | -$1.14M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$629K |
| 5 |
Citigroup
New York
|
-$589K |